Arteriogenic Therapy by Intramyocardial Sustained Delivery of a Novel Growth Factor Combination Prevents Chronic Heart Failure - Concepedia

Concepedia

Publication | Closed Access

Arteriogenic Therapy by Intramyocardial Sustained Delivery of a Novel Growth Factor Combination Prevents Chronic Heart Failure

82

Citations

31

References

2011

Year

Sébastien Banquet, Élodie Gomez, Lionel Nicol, Florence Edwards‐Lévy, Jean‐Paul Henry, Renhai Cao, Damien Schapman, Brigitte Dautréaux, Françoise Lallemand, Fabrice Bauer,

Abstract

Our data showing the selective advantage of using fibroblast growth factor-2 together with hepatocyte growth factor suggest that this growth factor combination may constitute an efficient novel treatment for chronic heart failure.

References

	Year	Citations

Page 1